
    
      Selinexor is an oral, first in class, slowly reversible, potent and Selective Inhibitor of
      Nuclear Export (SINE) compound that specifically blocks Exportin 1 (XPO1). It is one of the
      most promising investigational drugs available for this patient with clear risk and benefit
      assessment favoring potential benefit.
    
  